Bayer submits riociguat NDA

Bayer AG (Xetra:BAYN) submitted an NDA to FDA for riociguat to treat pulmonary arterial hypertension (PAH) and persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after surgical...